Abstract
Results There was no significant difference between groups that underwent on-pump coronary bypass surgery in terms of mean units of blood and blood products used (p > 0.05). The percentage of blood product use was 54.5% in salicylate receivers and 55.6% in non-receivers. There was no significant difference between groups of patients that underwent off-pump beating heart coronary surgery in terms of amount of blood and blood product used (p > 0.05). The percentage of blood product use was 37.5% in salicylate receivers and 50% in non-receivers in this group of patients (p > 0.05). Conclusions When the amount blood and blood products used was investigated for patients undergoing either on-pump or off-pump coronary bypass in terms of salicylate use, no significant difference was detected between groups.
Highlights
In this study, we aimed to present whether there was a significant difference between patients receiving 100 mg salicylate and not receiving salicylate before coronary artery bypass grafting in terms of amount of postoperative use of blood and blood products
When the amount blood and blood products used was investigated for patients undergoing either on-pump or off-pump coronary bypass in terms of salicylate use, no significant difference was detected between groups
There was no significant difference between groups that underwent on-pump coronary bypass surgery in terms of mean units of blood and blood products used (p > 0.05)
Summary
We aimed to present whether there was a significant difference between patients receiving 100 mg salicylate and not receiving salicylate before coronary artery bypass grafting in terms of amount of postoperative use of blood and blood products
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have